The nation of Zimbabwe has rejected a substantial American health deal worth $367m (272 million pounds) over five years due to the United States' demand for confidential biological samples.
This rejection was revealed after a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the deal was "skewed".
An official representative later explained that the United States was demanding access to health data for research and commercial purposes but was not willing to share the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for more negotiations to secure a deal agreeable to all parties so the nation's vital HIV programme can continue.
Broader Background
This development follows a similar situation in Kenya, where a high court blocked a related health funding agreement following concerns were filed about the security of citizens' medical information.
Since resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump argued its spending was "wasteful" and his administration was pursuing direct bilateral agreements to enhance transparency and responsibility.
According to reports, 16 African countries have so far agreed to similar health pacts, constituting over $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Effectively, our country would provide the basic resources for scientific discovery without any assurance that the resulting innovations would be accessible to our people should a new disease outbreak emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were undermining systems already set up via the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage future global health emergencies.
"This framework is designed to guarantee that when a country provides its information, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."
These objections over the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage further discussions with our American counterparts on how future co-operation could be designed in a manner that respects the independence and interests of each country."
Health Experts Reaction
Medical experts expressed it understood the official position, but recommended that negotiations should continue given that much of the nation's Aids initiatives relied on international support.
"Where specific concerns arise, including those involving information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it said.
The halted deal underscores the ongoing debate between accepting much-needed foreign assistance and safeguarding national sovereignty in an ever more data-driven world.